Skip to main content
HR 4460 116th Congress House Health Administrative law and regulatory procedures Alternative treatments Appropriations Child health Congressional oversight Crime prevention Criminal procedure and sentencing Department of Health and Human Services Department of Justice Disability and health-based discrimination Drug safety, medical device, and laboratory regulation Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Education programs funding Elementary and secondary education Emergency medical services and trauma care Employment and training programs Executive agency funding and structure

Turn the Tide Act

Introduced: September 24, 2019 See on congress.gov
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 28, 2019
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Sep 25, 2019
Referred to the Subcommittee on Health.
Sep 24, 2019
Referred to the Subcommittee on Health.
Sep 24, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, the Judiciary, Oversight and Reform, Education and Labor, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 24, 2019
Introduced in House
 Plain-English summary Congressional Research Service

Turn the Tide Act

This bill funds through FY2023 the SUPPORT for Patients and Communities Act, which established various programs to address opioid addiction. Funded programs include (1) grants to increase access to substance use disorder treatments; (2) research, training, and developing best practices within the public health sector; (3) prevention and recovery services for youth, women, and infants; (4) overdose prevention and treatment; and (5) other community, judicial, and administrative programs. The bill also reauthorizes through FY2024 and increases funding for the Opioid State Targeted Response grants program and reauthorizes through FY2029 and increases funding for the Substance Abuse Prevention and Treatment Block Grant program.

Further, the bill prohibits health insurance plans, including Medicaid, from requiring prior authorization for medication-assisted treatment for opioid addiction. Plans also must cover at least one overdose-reversing drug without any cost-sharing requirement. The bill also revises Medicaid to require state payments to providers of mental and behavioral health services for substance use disorders and extends funding for demonstration projects that link provider payments to certain metrics. The bill also targets loan repayments for substance use disorder treatment professionals to states with the highest rates of drug overdoses.

Additionally, separate payment classifications must be established for specified procedures covered by Medicare that utilize non-opioid drugs to treat pain after surgery. The bill also (1) establishes grant programs to support responses to children exposed to trauma, (2) expands support for the drug-free communities program, and (3) funds peer-mentoring pilot programs for law enforcement agencies.

What's happening now October 28, 2019

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

 Committees of jurisdiction 9